These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 526934)

  • 21. Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid].
    Turrisi AT; Glover DJ; Hurwitz S; Glick J; Norfleet AL; Weiler C; Yuhas JM; Kligerman MM
    Cancer Treat Rep; 1986 Dec; 70(12):1389-93. PubMed ID: 2431774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I clinical evaluation of anguidine.
    Murphy WK; Burgess MA; Valdivieso M; Livingston RB; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1978 Oct; 62(10):1497-502. PubMed ID: 361224
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I evaluation and pharmacokinetic study of weekly iv thymidine and 5-FU in patients with advanced colorectal carcinoma.
    Lynch G; Kemeny N; Chun H; Martin D; Young C
    Cancer Treat Rep; 1985 Feb; 69(2):179-84. PubMed ID: 3971391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of N-methylformamide in patients with advanced cancer.
    Ettinger DS; Orr DW; Rice AP; Donehower RC
    Cancer Treat Rep; 1985 May; 69(5):489-93. PubMed ID: 4005871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of tricyclic nucleoside phosphate.
    Mittelman A; Casper ES; Godwin TA; Cassidy C; Young CW
    Cancer Treat Rep; 1983 Feb; 67(2):159-62. PubMed ID: 6825123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of pentamethylmelamine: a clinical and pharmacologic study.
    Ihde DC; Dutcher JS; Young RC; Cordes RS; Barlock AL; Hubbard SM; Jones RB; Boyd MR
    Cancer Treat Rep; 1981; 65(9-10):755-62. PubMed ID: 6791819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).
    Judson IR; Calvert AH; Rutty CJ; Abel G; Gumbrell LA; Graham MA; Evans BD; Wilman DE; Ashley SE; Cairnduff F
    Cancer Res; 1989 Oct; 49(19):5475-9. PubMed ID: 2670205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.
    Egorin MJ; Sigman LM; Van Echo DA; Forrest A; Whitacre MY; Aisner J
    Cancer Res; 1987 Jan; 47(2):617-23. PubMed ID: 3791246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methyl-GAG in patients with malignant neoplasms: a phase I re-evaluation.
    Hart RD; Ohnuma T; Holland JF; Bruckner H
    Cancer Treat Rep; 1982 Jan; 66(1):65-71. PubMed ID: 7053268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM; Silver HK
    Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I evaluation of IMPY in a twice weekly schedule.
    Haas CD; Joseph U; Belt RJ; Hoogstraten B
    Cancer Treat Rep; 1981; 65(5-6):439-41. PubMed ID: 7237464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An abbreviated phase II trial of thalicarpine.
    Leimert JT; Corder MP; Elliott TE; Lovett JM
    Cancer Treat Rep; 1980; 64(12):1389-90. PubMed ID: 6451289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of anguidine in mice.
    Conner MW; de Camargo J; Punyarit P; Riengropitak S; Rogers AE; Newberne PM
    Fundam Appl Toxicol; 1986 Jul; 7(1):153-64. PubMed ID: 3732667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The acute toxicopathy of intravenous diacetoxyscirpenol (anguidine) administration in swine.
    Coppock RW; Gelberg HB; Hoffmann WE; Buck WB
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1034-49. PubMed ID: 4092867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusion.
    Ohnuma T; Nogeire C; Cuttner J; Holland JF
    Cancer; 1978 Oct; 42(4):1670-9. PubMed ID: 152143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of anguidine toxicity in rats by atropine and methylatropine.
    Malarkey DE; Conner BH; Rogers AE; Conner MW; Newberne PM
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):512-24. PubMed ID: 2609347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phase I Study of RA-700. RA-700 Clinical Study Group].
    Majima H; Tsukagoshi S; Furue H; Suminaga M; Sakamoto K; Wakabayashi R; Kishino S; Niitani H; Murata A; Genma A
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):67-78. PubMed ID: 8422188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trichothecenes, 1: The synthesis of 4-deoxyverrucarol from verrucarol and diacetoxyscirpenol.
    Schuda PF; Potlock SJ; Wannemacher RW
    J Nat Prod; 1984; 47(3):514-9. PubMed ID: 6481362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.